Next Article in Journal
The Emerging Role of Pattern Recognition Receptors in the Pathogenesis of Malaria
Next Article in Special Issue
Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment
Previous Article in Journal
Repurposing Plant Virus Nanoparticles
Previous Article in Special Issue
Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice
Open AccessReview

Meningococcal Vaccines: Current Status and Emerging Strategies

Department of Chemistry, Morgan State University, Baltimore, MD 21251, USA
Author to whom correspondence should be addressed.
Vaccines 2018, 6(1), 12;
Received: 30 January 2018 / Revised: 21 February 2018 / Accepted: 23 February 2018 / Published: 25 February 2018
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world. There are a number of vaccines (polysaccharide-based, glycoconjugate, protein-based and combined conjugate vaccines) that are approved to target five of the six disease-causing serogroups of the pathogen. Immunization strategies have been effective at helping to decrease the global incidence of meningococcal meningitis. Researchers continue to enhance these efforts through discovery of new antigen targets that may lead to a broadly protective vaccine and development of new methods of homogenous vaccine production. This review describes current meningococcal vaccines and discusses some recent research discoveries that may transform vaccine development against N. meningitidis in the future. View Full-Text
Keywords: Neisseria meningitidis; glycoconjugate vaccines; protein-based vaccines; vaccine development Neisseria meningitidis; glycoconjugate vaccines; protein-based vaccines; vaccine development
Show Figures

Figure 1

MDPI and ACS Style

McCarthy, P.C.; Sharyan, A.; Sheikhi Moghaddam, L. Meningococcal Vaccines: Current Status and Emerging Strategies. Vaccines 2018, 6, 12.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop